HOME >> MEDICINE >> NEWS
Harvard Medical School and Project A.L.S. join forces to target ALS research

Boston, MA - Harvard Medical School (HMS) and Project A.L.S., a non-profit organization that funds research seeking effective treatments and a cure for ALS, have agreed to join forces to advance ALS research. Across Harvard, they will identify and pursue unique research opportunities for understanding and treating ALS, and will fundraise toward a projected two-year, multi-million dollar goal in support of that research.

Through their new collaboration, HMS and Project A.L.S. are teaming up together to accelerate progress toward mutual goals.

"We founded Project A.L.S. in 1998, aiming to put the first strong medicine into place," said Meredith Estess, president of Project A.L.S., a nimble, young organization that actively recruits new ideas and renowned scientists to ALS. "We learned that the fastest way to our goal was recruiting the best and brightest researchers throughout science and technology, and uniting them in true collaboration. For that reason we're thrilled about our new relationship with Harvard Medical School. This initiative promises to help us realize our translational goals faster."

"The mission of HMS is to create and nurture a community of the best people committed to leadership in alleviating human suffering caused by disease," said HMS dean, Dr. Joseph B. Martin. "This new collaboration with Project A.L.S. is one way to help advance the Medical School's mission," he said.

ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease and motor neuron disease, is a progressive, fatal disorder related to Parkinson's, Alzheimer's, and Huntington's diseases. There are no effective treatments for ALS.

The new initiative will focus on four areas of research:

  • the genetics of ALS susceptibility;
  • stem cell therapy;
  • drug discovery; and * new approaches for treatment delivery to the central nervous system.

    Guiding the new initiative is longtime ALS researcher Dr. Robert Brow
    '"/>




  • 25-May-2005


    Page: 1 2

    Related medicine news :

    1. IADR to present Behavioral Science Award to Harvards Douglass
    2. U-M, Harvard team propose way to make the most of health dollars
    3. Karolinska Institute and Harvard in a unique training initiative
    4. New Harvard Health Publications book
    5. University of Queensland and Harvard Medical International to nourish the health workforce
    6. Albert Szent-Gyrgyi Prize for Progress in Cancer Research to Harvards Harold F. Dvorak, M.D.
    7. Al Gore recipient of Harvard Global Environmental Citizen Award
    8. Harvard doc health habits
    9. Harvard scientists report public health impact of 1990 Iraq invasion of Kuwait
    10. Medical residents score poorly in diagnosing and managing tuberculosis
    11. Medical residents unclear about TB guidelines

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: Harvard Medical School and Project join forces target ALS research

    (Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
    (Date:3/4/2015)... 04, 2015 FDA’s New Inspection Approach:, ... Webinar**, March 24, 2015 — 1:30 p.m. – 3:00 ... know within four hours of an inspection whether a ... on their “good” list, they’ll merely ask for reassurance ... is on the “bad” list, the manufacturer must get ...
    (Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
    (Date:3/4/2015)... March 04, 2015 With the growing influence ... lives of our teens and young adults, combined with the ... and confusing to try to keep up with what kids ... or trend is replaced on a daily basis. , The ... and the slang that is used to discreetly talk about ...
    (Date:3/4/2015)... York (PRWEB) March 04, 2015 More ... the cardiovascular risks potentially associated with low testosterone treatments ... (FDA) announced that it will now require manufacturers to ... their risk for heart attacks and strokes. In a ... the agency also stated that it was requiring testosterone ...
    Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4
    (Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... in Miami, FL on Wednesday, March ... webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
    (Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
    (Date:3/4/2015)...  Results of the recent study, Results From ... Intra-Operative Positive Margin Detection , were presented as part ... Annual Miami Breast Cancer Conference last week. ... , MD, FACS, Professor of Surgery at the Sackler ... analysis of MarginProbe,s efficiency and accuracy when used consecutively ...
    Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2
    Cached News: